Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Pigmentation Disorders Treatment Market Portraiture
2.2. Global Pigmentation Disorders Treatment Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Pigmentation Disorders Treatment Market, by Disease Type, 2017 (US$ Mn)
2.4. Global Pigmentation Disorders Treatment Market, by Geography, 2017 (US$ Mn)
Chapter 3. Pigmentation Disorders Treatment Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Pigmentation Disorders Treatment Market, by Key Players, 2017
Chapter 4. Global Pigmentation Disorders Treatment Market, by Treatment Type
4.1. Overview
4.2. Topical Drugs
4.3. Chemical Peels
4.4. Microdermabrasion
4.5. Phototherapy
4.6. Laser Therapy
Chapter 5. Global Pigmentation Disorders Treatment Market, by Disease Type
5.1. Overview
5.2. Melasma
5.3. Albinism
5.4. Vitiligo
5.5. Post-Inflammatory Hyperpigmentation
5.6. Others (Solar Lentigines, Acne Vulgaris, etc.)
Chapter 6. Global Pigmentation Disorders Treatment Market, by Geography
6.1. Overview
6.2. North America Pigmentation Disorders Treatment Market Analysis, 2016 – 2026
6.2.1. North America Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
6.2.2. North America Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
6.2.3. North America Pigmentation Disorders Treatment Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Pigmentation Disorders Treatment Market Analysis, 2016 – 2026
6.3.1. Europe Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe Pigmentation Disorders Treatment Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Pigmentation Disorders Treatment Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Pigmentation Disorders Treatment Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Pigmentation Disorders Treatment Market Analysis, 2016 – 2026
6.5.1. Latin America Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Pigmentation Disorders Treatment Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Pigmentation Disorders Treatment Market Analysis, 2016 – 2026
6.6.1. MEA Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA Pigmentation Disorders Treatment Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. ALLERGAN PLC
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bayer AG
7.3. Galderma S.A.
7.4. EpiPharm AG
7.5. Pierre Fabre Laboratories
7.6. La Roche-Posay Laboratoire Pharmaceutique
7.7. Obagi Cosmeceuticals LLC
7.8. RXi Pharmaceuticals Corporation
7.9. SkinCeuticals, Inc.
7.10. Vivier Pharma, Inc.
List of Figures
FIG. 1 Pigmentation Disorders Treatment: Research Methodology
FIG. 2 Pigmentation Disorders Treatment: Market Segmentation
FIG. 3 Global Pigmentation Disorders Treatment Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global Pigmentation Disorders Treatment Market, by Disease Type, 2017 (US$ Mn)
FIG. 5 Global Pigmentation Disorders Treatment Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global Pigmentation Disorders Treatment Market, by Key Players, 2017
FIG. 8 Global Topical Drugs Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 9 Global Chemical Peels Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 10 Global Microdermabrasion Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 11 Global Phototherapy Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 12 Global Laser Therapy Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 13 Global Melasma Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 14 Global Albinism Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 15 Global Vitiligo Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 16 Global Post-Inflammatory Hyperpigmentation Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 17 Global Other Disease Type Market for Pigmentation Disorders Treatment, 2016 – 2026 (US$ Mn)
FIG. 18 U.S. Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 23 China Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Middle East and Africa Pigmentation Disorders Treatment Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Pigmentation Disorders Treatment Market Portraiture
TABLE 2 Global Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Pigmentation Disorders Treatment Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Pigmentation Disorders Treatment Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe America Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Pigmentation Disorders Treatment Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Pigmentation Disorders Treatment Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Pigmentation Disorders Treatment Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Pigmentation Disorders Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Pigmentation Disorders Treatment Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Pigmentation Disorders Treatment Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 ALLERGAN PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Galderma S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Epipharm AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Pierre Fabre Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 La Roche-Posay Laboratorie Pharmaceutique: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Obagi Cosmeceuticals LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 RXi Pharmaceuticals Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 SkinCeuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vivier Pharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)